- Investigational New Drug (IND) application submitted to the U.S. Food and Drug administration (FDA)
- Plans in place to initiate a Human clinical trial in 60 healthy volunteers in the USA
- Clinical Trial to examine a dosing regimen for Travelan more suited for use by the US military
- Infectious diarrhea is the most common illness reported by travelers
Why Li Auto Stock Is Rising
Li Auto Inc (NASDAQ: LI) shares are trading higher by 3.4% to $34.95 Wednesday afternoon after the company announced October deliveries of 40,422, up 302.1% from last year.
